Phthalazinones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07875614

ABSTRACT:
Compounds of the formula I, in which R, R1, R2, R3, R4, R5, R6, R7, R8, Z1, Z2, Z3and Y1have the meanings indicated in claim1, can be employed, inter alia, for the treatment of tumours

REFERENCES:
patent: 3864343 (1975-02-01), Inoue et al.
patent: 6180629 (2001-01-01), Wang et al.
patent: 7714151 (2010-05-01), Kelly et al.
patent: 22 38 566 (1973-02-01), None
patent: WO 03/014090 (2003-02-01), None
Vaughan, et al., The Preparation of Some Phthalazines and Related Substances, Journal of the American Chemical Society American Chemical Society, vol. 68, pp. 1314-1316 (1946).
Bernard, et al., A New and Efficient Synthesis of Phthalazin-1(2H)-ones, Synthesis, pp. 317-320 (1998).
Al-Awadhi, et al., New Synthetic Approaches to Condensed Pyridazinones: Aklylpyridazinyl Carbonitriles . . . , Tetrahedron, vol. 51, pp. 12745-12762 (1995).
Elnagdi, et al., Studies on Alkyl Heterocyclic Aromatic Compounds: New Routes for the Synthesis of Polyazanaphthalenes, Verlag der Zeitschrift für Naturforschung, pp. 683-689 (1998).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phthalazinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phthalazinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phthalazinones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2664508

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.